A recent study explored potential barriers, such as sociodemographic and clinical factors, to receiving EGFR test results prior to treatment initiation in patients with stage IV non-small cell lung cancer (NSCLC).
Jeffrey Scott, MD, chief medical…
A recent study explored potential barriers, such as sociodemographic and clinical factors, to receiving EGFR test results prior to treatment initiation in patients with stage IV non-small cell lung cancer (NSCLC).
Jeffrey Scott, MD, chief medical…